Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

Slični predmeti

• Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
  od: Valmori, D, i dr.
  Izdano: (1999)
• A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
  od: van der Bruggen, P, i dr.
  Izdano: (1994)
• Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
  od: Romero, P, i dr.
  Izdano: (1998)
• Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
  od: Oelke, M, i dr.
  Izdano: (2000)
• Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
  od: Valmori, D, i dr.
  Izdano: (1999)